Bachem

Bachem is a Swiss biotechnology company founded in 1971, specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience, Bachem serves pharmaceutical and biotechnology companies globally, providing products for research, clinical development, and commercial applications. The company is headquartered in Bubendorf, Switzerland, and has production sites in Europe, the United States, and the United Kingdom, along with a sales office in Tokyo. Bachem's core business includes Custom Synthesis and Core Products, focusing on peptides and complex organic compounds as active pharmaceutical ingredients (APIs). The company adheres to Good Manufacturing Practice (GMP) guidelines, ensuring high-quality standards. Its product portfolio features peptides for pharmaceutical use, oligonucleotides for therapeutic applications, and peptide-based biochemicals for research. Bachem also offers custom synthesis, process development, and scale-up manufacturing services to support drug development. The company emphasizes sustainability, innovation, and customer centricity as part of its strategic vision.